头颈癌术后生活质量:ACRIN 6685研究证据
ACRIN 6685试验前瞻性纳入230例临床N0期头颈鳞癌患者,采用华盛顿大学生存质量量表评估择区性颈清扫术后2年内健康相关生活质量轨迹。术后总体健康相对癌症前显著下降5.8分(p=0.048),总体生活质量显著下降4.3分(p=0.031),1-2年内恢复至接近或优于基线。
要点
- 术后总体健康相对癌症前下降5.8分(p=0.048),1年时高于基线3.0分(p=0.65)。
- 术后总体生活质量下降4.3分(p=0.031),后恢复至与基线无显著差异。
- 近7天总体健康各随访点与基线无显著差异。
核心结论
- N0期头颈鳞癌患者术后即出现健康相关生活质量显著下降,1-2年内恢复至接近或优于基线。
研究设计与样本
- ACRIN 6685试验的前瞻性队列,纳入230例接受择区性颈清扫的临床N0期头颈鳞癌患者,用华盛顿大学生存质量量表随访至术后2年。
主要发现
- 近7天总体健康各随访点与基线无显著差异。
- 总体健康相对癌症前术后显著下降5.8分(p=0.048),1年时高于基线3.0分(p=0.65)。
- 总体生活质量术后显著下降4.3分(p=0.031),后恢复至与基线无显著差异。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study examined the trajectory of health-related quality of life (HRQoL) for patients with clinical stage N0 HNSCC enrolled in ACRIN 6685 who underwent elective neck dissection(s). METHODS: HRQoL of 230 patients in the ACRIN 6685 trial was measured prospectively up to 2 years following surgery using the University of Washington Quality of Life instrument. RESULTS: General Health Within the Last 7 Days did not differ significantly from baseline at any follow-up. General Health Relative to Before Cancer fell significantly by 5.8 points following surgery (p = 0.048), and then returned to 3.0 points above baseline at 1 year (p = 0.65). For Overall Quality of Life, HRQoL fell significantly by 4.3 points following surgery (p = 0.031) and then returned to levels not significantly different from baseline. CONCLUSIONS: Patients with stage N0 HNSCC experience significant declines in HRQoL immediately following surgery, including neck dissection, which recovers to near or better than baseline within 1-2 years.
引用
- Hollenbeak CS, Duan F, Subramaniam RM, et al. Quality of life following surgery for head and neck cancer: Evidence from ACRIN 6685. Head Neck. 2024. PMID: 38353324. doi:10.1002/hed.27673
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。